Loading company…
Melinta Therapeutics develops small-molecule antibiotics for serious infections.
Founded in 2000 and formerly known as Rib-X Pharmaceuticals, Melinta Therapeutics develops small-molecule antibiotics for serious infections, including hospital gram-negative infections.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in